Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms.

Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E.

AIDS Res Ther. 2007 Jun 27;4:14.

2.

Adipose tissue biology and HIV-infection.

Giralt M, Domingo P, Villarroya F.

Best Pract Res Clin Endocrinol Metab. 2011 Jun;25(3):487-99. doi: 10.1016/j.beem.2010.12.001. Review.

PMID:
21663842
3.
4.

HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.

Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E.

AIDS Res Ther. 2007 Jul 16;4:16.

5.

The regulation of adipose tissue distribution in humans.

Björntorp P.

Int J Obes Relat Metab Disord. 1996 Apr;20(4):291-302. Review.

PMID:
8680455
6.

Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy.

Grunfeld C, Thompson M, Brown SJ, Richmond G, Lee D, Muurahainen N, Kotler DP; Study 24380 Investigators Group..

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):286-97.

PMID:
17592343
7.

HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy.

Fliers E, Sauerwein HP, Romijn JA, Reiss P, van der Valk M, Kalsbeek A, Kreier F, Buijs RM.

Lancet. 2003 Nov 22;362(9397):1758-60.

PMID:
14643128
8.

"Buffalo hump" in men with HIV-1 infection.

Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M.

Lancet. 1998 Mar 21;351(9106):867-70.

PMID:
9525364
9.

Long-term changes in adipose tissue in human disease.

Pond CM.

Proc Nutr Soc. 2001 Aug;60(3):365-74. Review.

PMID:
11681811
10.
11.

Syndrome of body fat redistribution in HIV-1-infected patients: relationships to cortisol and catecholamines.

Renard E, Fabre J, Paris F, Reynes J, Bringer J.

Clin Endocrinol (Oxf). 1999 Aug;51(2):223-30.

PMID:
10468994
12.

Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis.

Grant RW, Stephens JM.

Am J Physiol Endocrinol Metab. 2015 Aug 1;309(3):E205-13. doi: 10.1152/ajpendo.00053.2015. Epub 2015 Jun 9. Review.

13.
14.

Pathophysiology of the HIV-Associated Lipodystrophy Syndrome.

Fève B, Glorian M, Hadri KE.

Metab Syndr Relat Disord. 2004 Fall;2(4):274-86. doi: 10.1089/met.2004.2.274.

PMID:
18370696
15.

Sympathetic nervous system function in HIV-associated adipose redistribution syndrome.

van Gurp PJ, Tack CJ, van der Valk M, Reiss P, Lenders JW, Sweep FC, Sauerwein HP.

AIDS. 2006 Mar 21;20(5):773-5.

PMID:
16514309
16.

In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy.

Huda SS, Forrest R, Paterson N, Jordan F, Sattar N, Freeman DJ.

Hypertension. 2014 May;63(5):1094-101. doi: 10.1161/HYPERTENSIONAHA.113.01824. Epub 2014 Mar 3.

17.

Pharmacologic therapy for HIV-associated lipodystrophy.

Benavides S, Nahata MC.

Ann Pharmacother. 2004 Mar;38(3):448-57. Epub 2004 Jan 30. Review.

PMID:
14755064
18.

Pathophysiology of dyslipidemia in Cushing's syndrome.

Arnaldi G, Scandali VM, Trementino L, Cardinaletti M, Appolloni G, Boscaro M.

Neuroendocrinology. 2010;92 Suppl 1:86-90. doi: 10.1159/000314213. Epub 2010 Sep 10. Review.

PMID:
20829625
19.

Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction.

Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R.

J Physiol Pharmacol. 2007 Dec;58(4):591-610. Review.

20.

Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy.

Hadigan C, Borgonha S, Rabe J, Young V, Grinspoon S.

Metabolism. 2002 Sep;51(9):1143-7.

PMID:
12200758

Supplemental Content

Support Center